Profound Medical (PROF) vs Quanterix (QTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Profound Medical (PROF) has outperformed Quanterix (QTRX) over the past year, losing 12.1% versus a loss of 41.3%. Over five years, PROF leads with a -62.2% price change compared with -93.6% for QTRX. Profound Medical is the larger company by market cap ($252.5 million vs $151.8 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PROF | QTRX |
|---|---|---|
| Share price | $6.91 | $3.21 |
| Market cap | $252.49M | $151.81M |
| 1-day change | +21.65% | -3.46% |
| YTD return | -27.83% | -47.72% |
| 1-year return | -12.07% | -41.25% |
| 5-year return | -62.16% | -93.57% |
| EPS (TTM) | $-0.99 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.95 | $8.77 |
| 52-week low | $4.80 | $2.15 |
| Distance from 52-week high | -22.79% | -63.40% |
| Analyst consensus | none | none |
| Avg. price target upside | +61.22% | -6.54% |
| Average volume | 124.80K | 762.14K |
| Shares outstanding | 36.54M | 47.29M |
| Employees | 162 | 450 |
| Sector | Health Care | Industrials |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PROF has outperformed QTRX by 29.2 percentage points over the past year.
- The two companies sit in different sectors: Profound Medical in Health Care and Quanterix in Industrials.
About Profound Medical
PROF stock →Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.
Health Care · Medical/Dental Instruments · 162 employees
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
PROF vs QTRX FAQ
Which is bigger, Profound Medical or Quanterix?
Profound Medical (PROF) is larger, with a market capitalization of $252.49M compared with $151.81M for Quanterix (QTRX).
Which stock has performed better over the past year, PROF or QTRX?
PROF returned -12.07% over the past 12 months, compared with -41.25% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Profound Medical and Quanterix in the same industry?
No. Profound Medical is in the Health Care sector, while Quanterix is in Industrials.